Updated:
Aditum Bio
Aditum Bio is a biotech venture firm committed to improving health by accelerating drug development in disease areas with high unmet need where medical...
Aditum Bio
Aditum Bio is a biotech venture firm committed to improving health by accelerating drug development in disease areas with high unmet need where medical innovation can have a significant impact. Aditum Bio in-licenses promising drug candidates and spins out individual companies dedicated to bringing each candidate through early clinical trials. It fosters an incubator model, focusing on the translational phase of drug development.
General information
Firm type
Private Equity
Year founded
2019
Location
Region
North America
Country
United States
City
Oakland
Corporate office
Oakland, United States
Principals
Joe Jimenez
Co-Founder and Managing Director
Josh Gertsman
Partner
Frequently asked questions
What is Aditum Bio?
Aditum Bio is a private equity headquartered in Oakland, United States.
When was Aditum Bio founded?
Aditum Bio was founded in 2019.
Where is Aditum Bio headquartered?
Aditum Bio is headquartered in Oakland, United States, in the North America region.
What does Altss track for Aditum Bio?
Altss maintains an OSINT-verified profile of Aditum Bio covering investment focus (ESG policy, ticket size, target IRR, currency preference, regional focuses, industry focuses, technological focuses), team (service providers and advisors), deals (company deals and fund commitments), and network (associations and event participation). Detailed values are available to Altss subscribers.
What is Aditum Bio's website?
Aditum Bio's public website is www.aditumbio.com. Verified contact details for principals and decision-makers are available to Altss subscribers.
What type of firm is Aditum Bio?
Aditum Bio is classified by Altss as a Private Equity, operating from United States within the North America region.
How does Altss source intelligence on Aditum Bio?
Altss combines OSINT (open-source intelligence) with regulatory filings, public disclosures, and licensed data partners. Source provenance is tracked to support compliance-ready research workflows.
When was Aditum Bio's Altss profile last updated?
Aditum Bio's profile on Altss was last refreshed on August 11, 2026. Continuous updates are applied as new public information is verified.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: